Table 2.
Summary of meta-analytic results.
| Sex | K | N | Overall Rate of Expression (95% CI), % |
Q | I2 | |
|---|---|---|---|---|---|---|
|
Human epidermal growth factor Receptor 2
(HER 2/neu) |
F M |
20 12 |
341 209 |
32 (27–38) 26 (18–36) |
23.74 26.04 |
19.98 57.76 |
| Estrogen Receptor (ER) | F M |
5 2 |
108 10 |
12 (3–36) 9 (0–68) |
17.30 3.57 |
76.88 72.02 |
| Androgen Receptor (AR) | F M |
7 5 |
140 87 |
40 (34–47) 40 (32–48) |
4.79 0.18 |
0.00 0.00 |
|
Progesterone Receptor
(PR) |
F M |
4 1 |
95 5 |
9 (3–25) 2 (0–22) |
5.19 - |
42.15 - |
Note. F: female; M: male; K: number of studies; N: total number of patients; CI: confidence interval; I2: index for quantifying the degree of heterogeneity; Q: test for heterogeneity; p < 0.001.